Berberine enhances antidiabetic effects and attenuates untoward effects of canagliflozin in streptozotocin-induced diabetic mice
Authors:
- 1 July 2016
- journal article
- Published by Elsevier in Chinese Journal of Natural Medicines
- Vol. 14 (7) , 518-526
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studiesBiochemistry and Cell Biology, 2015
- Beneficial Effects of Canagliflozin in Combination with Pioglitazone on Insulin Sensitivity in Rodent Models of Obese Type 2 DiabetesPLOS ONE, 2015
- Adverse effects and safety of SGLT-2 inhibitorsDiabetes & Metabolism, 2014
- Berberine Improves Kidney Function in Diabetic Mice via AMPK ActivationPLOS ONE, 2014
- Canagliflozin in Asian patients with type 2 diabetes on metformin alone or metformin in combination with sulphonylureaDiabetes, Obesity and Metabolism, 2014
- Canagliflozin Provides Durable Glycemic Improvements and Body Weight Reduction Over 104 Weeks Versus Glimepiride in Patients With Type 2 Diabetes on Metformin: A Randomized, Double-Blind, Phase 3 StudyDiabetes Care, 2014
- CanagliflozinJAAPA, 2014
- Effect of Insulin‐Induced Hypoglycaemia on the Peripheral Nervous System: Focus on Adaptive Mechanisms, Pathogenesis and Histopathological ChangesJournal of Neuroendocrinology, 2014
- Effects and Action Mechanisms of Berberine and Rhizoma coptidis on Gut Microbes and Obesity in High-Fat Diet-Fed C57BL/6J MicePLOS ONE, 2011
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participantsThe Lancet, 2011